Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Immunophilin-sensitive protein phosphatase action in cell signaling pathways.

Schreiber SL.

Cell. 1992 Aug 7;70(3):365-8. Review. No abstract available.

PMID:
1379518
2.

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL.

Cell. 1991 Aug 23;66(4):807-15.

PMID:
1715244
3.

Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.

Bierer BE.

Chem Immunol. 1994;59:128-55. No abstract available.

PMID:
7524531
4.

Lessons from molecular matchmakers.

Teague S.

Nat Struct Biol. 1995 May;2(5):360-1. No abstract available.

PMID:
7545076
5.

Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes.

Clipstone NA, Fiorentino DF, Crabtree GR.

J Biol Chem. 1994 Oct 21;269(42):26431-7.

6.

Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.

Cardenas ME, Hemenway C, Muir RS, Ye R, Fiorentino D, Heitman J.

EMBO J. 1994 Dec 15;13(24):5944-57.

7.

NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs.

McCaffrey PG, Perrino BA, Soderling TR, Rao A.

J Biol Chem. 1993 Feb 15;268(5):3747-52.

8.

The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin.

Dawson TM, Steiner JP, Lyons WE, Fotuhi M, Blue M, Snyder SH.

Neuroscience. 1994 Sep;62(2):569-80.

PMID:
7530348
9.
10.

Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?

Schreier MH, Baumann G, Zenke G.

Transplant Proc. 1993 Feb;25(1 Pt 1):502-7. Review. No abstract available.

PMID:
7679818
11.

Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A.

Cardenas ME, Muir RS, Breuder T, Heitman J.

EMBO J. 1995 Jun 15;14(12):2772-83.

12.

Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex.

Wiederrecht G, Hung S, Chan HK, Marcy A, Martin M, Calaycay J, Boulton D, Sigal N, Kincaid RL, Siekierka JJ.

J Biol Chem. 1992 Oct 25;267(30):21753-60.

13.

Cyclosporin binding proteins. Identification, distribution, function and relation to FK binding proteins.

Ryffel B.

Biochem Pharmacol. 1993 Jul 6;46(1):1-12. Review. No abstract available.

PMID:
8394072
14.
15.
17.

Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.

Kunz J, Hall MN.

Trends Biochem Sci. 1993 Sep;18(9):334-8. Review.

PMID:
7694398
18.

Structure-based design of a cyclophilin-calcineurin bridging ligand.

Alberg DG, Schreiber SL.

Science. 1993 Oct 8;262(5131):248-50.

PMID:
8211144
19.

Binding of active cyclosporins to cyclophilin A and B, complex formation with calcineurin A.

Ryffel B, Woerly G, Murray M, Eugster HP, Car B.

Biochem Biophys Res Commun. 1993 Aug 16;194(3):1074-83.

PMID:
8394698
20.

When worlds collide: immunosuppressants meet protein phosphatases.

McKeon F.

Cell. 1991 Sep 6;66(5):823-6. Review. No abstract available.

PMID:
1716181
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk